rapportrx.comHealthcare / Healthcare softwareFounded: 2022Funding to Date: $250.18MM
Rapport Therapeutics is dedicated to crafting precision medicines tailored to the complexity of the human brain, marking a significant stride in the field of neuro medicines. Emphasizing a scientific partnership approach, they deliver revolutionary, relentless, and precise treatments. Their mission is to address neurological complexities with unmatched accuracy, leveraging cutting-edge research and development to create therapies that accurately match the nuanced needs of individuals.
View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Rapport Therapeutics.
Become part of the Secondary Marketplace, catering to both individual and institutional investors.